Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization
- PMID: 2817827
- DOI: 10.1002/ana.410260403
Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization
Abstract
Computer visualization techniques were used to map the distribution of dopaminergic neurons within midbrain tissue sections from 5 parkinsonian patients and 3 age-matched control subjects. The Parkinsonian brains had over 50% fewer dopaminergic neurons within the midbrain than age-matched normal brains. The cell loss occurred within the combined substantia nigra (dopaminergic nucleus A9) and retrorubral (dopaminergic nucleus A8) areas (greater than 61%) and the ventral tegmental area (dopaminergic nucleus A10) (greater than 42%). The cell loss was greatest within the ventral portion of the substantia nigra zona compacta. The specific pattern of cell loss is very similar to the pattern of cells that project to the striatum (as opposed to cortical and limbic sites) in animal neuroanatomical tracing experiments. These data suggest that Parkinson's disease preferentially destroys midbrain dopaminergic neurons in nuclei A8, A9, and A10, which project to the striatum.
Comment in
-
Deficiency of glutamate dehydrogenase in postmortem brain samples from parkinsonian putamen.Ann Neurol. 1990 Jul;28(1):111-2. doi: 10.1002/ana.410280128. Ann Neurol. 1990. PMID: 2115760 No abstract available.
Similar articles
-
Midbrain dopaminergic neurons (nuclei A8, A9, and A10): three-dimensional reconstruction in the rat.J Comp Neurol. 1993 May 15;331(3):297-309. doi: 10.1002/cne.903310302. J Comp Neurol. 1993. PMID: 8514911
-
Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease.Exp Neurol. 1997 Mar;144(1):202-13. doi: 10.1006/exnr.1997.6418. Exp Neurol. 1997. PMID: 9126172
-
Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.Ann Neurol. 1995 Mar;37(3):300-12. doi: 10.1002/ana.410370306. Ann Neurol. 1995. PMID: 7695230
-
Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.Ann Neurol. 2003;53 Suppl 3:S135-46; discussion S146-8. doi: 10.1002/ana.10482. Ann Neurol. 2003. PMID: 12666105 Review.
-
Biochemistry of Parkinson's disease with special reference to the dopaminergic systems.Mol Neurobiol. 1994 Aug-Dec;9(1-3):135-42. doi: 10.1007/BF02816113. Mol Neurobiol. 1994. PMID: 7888089 Review.
Cited by
-
Incubator embedded cell culture imaging system (EmSight) based on Fourier ptychographic microscopy.Biomed Opt Express. 2016 Jul 22;7(8):3097-110. doi: 10.1364/BOE.7.003097. eCollection 2016 Aug 1. Biomed Opt Express. 2016. PMID: 27570701 Free PMC article.
-
Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson's disease.J Neural Transm (Vienna). 2011 Mar;118(3):361-9. doi: 10.1007/s00702-010-0434-3. Epub 2010 Jun 17. J Neural Transm (Vienna). 2011. PMID: 20556443
-
Role of glial cells in neurotoxin-induced animal models of Parkinson's disease.Neurol Sci. 2011 Feb;32(1):1-7. doi: 10.1007/s10072-010-0424-0. Epub 2010 Nov 24. Neurol Sci. 2011. PMID: 21107876 Review.
-
Longitudinal Decline of Striatal Subregional [18F]FP-CIT Uptake in Parkinson's Disease.Nucl Med Mol Imaging. 2017 Dec;51(4):304-313. doi: 10.1007/s13139-017-0481-x. Epub 2017 Apr 6. Nucl Med Mol Imaging. 2017. PMID: 29242724 Free PMC article.
-
Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast.Biomolecules. 2015 Apr 23;5(2):617-34. doi: 10.3390/biom5020617. Biomolecules. 2015. PMID: 25915624 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical